Panelists discuss how recent clinical trials like ADmirable and DISCOVER intentionally enrolled patients with skin of color (Fitzpatrick types IV-VI), demonstrating similar efficacy and safety ...

Progress in medicine is made possible through the contributions of many people, including patients, families, caregivers, and health care professionals who support and participate in clinical research ...

The diversity of the general population is an important factor when determining the effectiveness of a new therapy. Although many trials are conducted on so-called experimental treatments, many ...

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...

Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...

PASSAGE was designed as a phase 4, multicenter clinical trial to evaluate its use in a broader patient population. Researchers enrolled 286 adults and adolescents in the study, and patients were ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

WALNUT CREEK, Calif. & FARGO, N.D.--(BUSINESS WIRE)--Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial services, have announced a strategic ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving faster, more effective clinical trials.

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...